ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
6.16
+0.18 (3.01%)
At close: Apr 16, 2024, 4:00 PM
6.11
-0.05 (-0.81%)
After-hours: Apr 16, 2024, 7:56 PM EDT

ADMA Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Revenue
258.22154.0880.9442.2229.3516.9922.7610.667.185.92
Upgrade
Revenue Growth (YoY)
67.59%90.36%91.72%43.85%72.79%-25.37%113.49%48.53%21.34%92.84%
Upgrade
Cost of Revenue
169.27118.8279.7761.2939.542.1929.166.364.313.74
Upgrade
Gross Profit
88.9435.271.17-19.07-10.16-25.21-6.44.32.872.17
Upgrade
Selling, General & Admin
59.0252.4642.935.0525.9122.518.758.496.754.82
Upgrade
Research & Development
3.33.613.655.912.343.935.577.697.029.52
Upgrade
Other Operating Expenses
4.9918.56134.893.018.658.585.454.623.85
Upgrade
Operating Expenses
67.3174.6359.5545.8431.2735.0832.9121.6318.3818.19
Upgrade
Operating Income
21.63-39.37-58.37-64.91-41.42-60.29-39.31-17.33-15.51-16.02
Upgrade
Interest Expense / Income
25.0319.2813.0611.998.995.523.292.241.841.29
Upgrade
Other Expense / Income
24.847.260.22-1.15-2.14-0.071.16-0.050.610.06
Upgrade
Pretax Income
-28.24-65.9-71.65-75.75-48.28-65.74-43.76-19.52-17.97-17.36
Upgrade
Income Tax
000000000-0.55
Upgrade
Net Income
-28.24-65.9-71.65-75.75-48.28-65.74-43.76-19.52-17.97-16.81
Upgrade
Shares Outstanding (Basic)
2241981408654452312109
Upgrade
Shares Outstanding (Diluted)
2241981408654452312109
Upgrade
Shares Change
13.19%41.77%62.03%58.51%20.27%97.37%88.39%16.72%12.06%42.27%
Upgrade
EPS (Basic)
-0.13-0.33-0.51-0.88-0.89-1.45-1.91-1.61-1.73-1.81
Upgrade
EPS (Diluted)
-0.13-0.33-0.51-0.88-0.89-1.45-1.91-1.61-1.73-1.81
Upgrade
Free Cash Flow
4.03-73.42-125.88-114.73-80.01-64.77-39.95-18.34-15.44-17.03
Upgrade
Free Cash Flow Per Share
0.02-0.37-0.90-1.33-1.47-1.43-1.75-1.51-1.48-1.83
Upgrade
Gross Margin
34.44%22.89%1.45%-45.17%-34.60%-148.42%-28.14%40.34%39.93%36.74%
Upgrade
Operating Margin
8.38%-25.55%-72.12%-153.75%-141.14%-354.95%-172.71%-162.56%-216.14%-270.79%
Upgrade
Profit Margin
-10.94%-42.77%-88.52%-179.41%-164.50%-387.06%-192.26%-183.05%-250.36%-284.22%
Upgrade
Free Cash Flow Margin
1.56%-47.65%-155.52%-271.74%-272.60%-381.36%-175.51%-172.05%-215.18%-287.85%
Upgrade
EBITDA
5.12-39.51-53.1-59.82-36.03-56.77-37.78-16.81-15.66-15.83
Upgrade
EBITDA Margin
1.98%-25.64%-65.60%-141.69%-122.76%-334.26%-165.99%-157.64%-218.14%-267.61%
Upgrade
Depreciation & Amortization
8.337.115.53.943.263.452.690.470.470.25
Upgrade
EBIT
-3.21-46.63-58.59-63.76-39.29-60.22-40.47-17.28-16.13-16.08
Upgrade
EBIT Margin
-1.24%-30.26%-72.39%-151.03%-133.86%-354.55%-177.82%-162.04%-224.69%-271.80%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).